Representative images of the indicated culture conditions that were analyzed to determine the percentage of cells with high levels of nuclear notch. The red corresponds to Notch, and the blue to the nuclear Hoechst stain. (E) An example of a grey-scale image of the Hoechst nuclear stain with the final boundaries determined by our MATLAB program traced in green. Traces in red are identified points that were discarded due to either small size or proximity to the image boundary. Several of the boundaries are larger than the area of the nuclear stain for that cell. This is due to the addition of the detected area of Notch fluorescence identified in (F), which shows the grayscale image of Notch fluorescence corresponding to the nuclear stain in (E). (G) The histogram of detected nucleus size for the growth media control. The vertical dashed green line indicates the cutoff for boundaries that are too small and most likely correspond to fluorescent debris or random noise in the image. Boundaries encompassing less than 120 pixels (i.e. to the left of the green line) were discarded. (H-K) Histograms of fluorescence intensity due to nuclear notch. Cells with a total fluorescence intensity of >2500 were considered to have high levels of nuclear Notch, and thus activated. The vertical dashed red lines indicate the cutoff for cells that are considered to be activated.
Supporting Information Materials/Methods
Harvesting of satellite cells from single muscle fibers: Un-injured EDL muscle was dissected from the hind leg of 3-month old C57/black-6 mouse and incubated at 37 o C in digestion medium (250 U/mL Collagenase type II (Sigma) in DMEM, buffered with 30 mM HEPES, pH 7) for 1 hour with gentle agitation 1 . Digested muscle was gently triturated through a flame-polished Pasteur pipet, fibers were settled briefly and pipetted to a tissue-culture dish in DMEM/F12 with 2 % horse serum. Single muscle fibers were hand picked under a microscope and satellite cells were liberated from three single fibers by digestion for one hour, with 1 U/mL Dispase (Gibco#17105-014) and 40 U/mL Collagenase type II in medium). Freshly isolated satellite cells were directly analyzed through the microfluidic device.
Culture of activated satellite cells from single muscle fibers: Un-injured EDL muscle was dissected from the hind leg of 3-month old C57/black-6 mouse and incubated at 37 o C in digestion medium (600 U/mL Collagenase type I (Sigma) in DMEM, buffered with 30 mM HEPES, pH 7) for 2 hours with gentle agitation 1 .. Digested muscle was gently triturated through a flame-polished Pasteur pipet, fibers were settled briefly and pipetted to a tissue culture dish in plating medium (DMEM/F12 with 2 % horse serum) for culture and activation overnight. Single fibers were hand picked under microscope and cultured in myoblast growth medium [DMEM/F12 with 10 % Bovine Growth Serum (Hyclone) and 5 ng/mL FGF-2], to further activate satellite cells for two days. Satellite cells were liberated from three single fibers by digestion for one hour, with 1 U/mL Dispase (Gibco) and 40 U/mL Collagenase type II in medium before analyzed with microfluidic devices.
Isolation and sorting of Sca-1-GFP myoblasts, and immunofluorescence staining: Fresh Sca-1-GFP muscle from a transgenic mouse 2 was digested and bulk myofibers with satellite cells were isolated as published 3 . Bulk fibers were cultured in myoblast growth medium (DMEM/F12 with 10 % Bovine Growth Serum (Hyclone) and 5 ng/mL FGF-2) for three days; myogenic cells were prepared from the culture as published 3 , and cultured for an additional day in growth medium on dishes coated with diluted Matrigel in PBS (3 µg/mL/cm 2 ). Myogenic cells were washed and lifted in PBS and live sorted by FACS on GFP for three populations: low/no GFP (21 %), intermediate GFP (34 %) and high GFP (17 %). The three populations were plated in Matrigel-coated chamber slides and cultured in growth medium overnight, then cultured in differentiation medium (2 % horse serum in DMEM) for four days. Cells were then imaged for GFP fluorescence, fixed in 4 % paraformaldehyde (5 minutes), and immunostained for embryonic myosin heavy chain (eMyHC) and GFP, as published.
Preparation of microchannel devices:
Negative-relief masters of the final microfluidic channel devices were fabricated on polished silicon wafers using standard soft lithography 4 . The microchannel's cross-sectional area, 25 µm x 25 µm, was chosen to be comparable to the size of the cells. The microchannel length of either 800 or 2000 µm ensured sufficient signal-to-noise ratio and transit-time resolution in our measurements 5 . PDMS (Sylgard 184) (10:1, pre-polymer : curing agent) was degassed and dispensed onto the master, and cured for 1 hour at 80°C. Prior to measurement, PDMS slabs with the embedded microchannel device were cut from each master. A 16 G syringe needle was used to core access holes into the PDMS slab.
Preparation of electrodes:
The electrodes were lithographically patterned onto RCA-cleaned glass substrates using Microposit S1813 (Dow) resist. A 75/250 Å Ti/Pt thin film was deposited using an electron-gun evaporator. Before sealing to the PDMS slab, the glass substrates were functionalized.
Device functionalization and assembly: Glass substrates were cleaned in a 10:1:1 RCA solution heated to 80°C for 5 min, followed by a thorough rinse in DI water. To functionalize the glass substrate area between the electrodes with antibodies, a temporary PDMS microchannel, created with soft lithography, was aligned between the electrodes and hermetically (reversibly) sealed to the substrate. This microchannel served as a patterning guide and ensured that only the region between the electrodes was silanized. A solution of 1M sodium hydroxide (Fisher Scientific) was injected into the microchannel for 10 min. The solution was then removed from the microchannel, and the devices were heated to 150°C for 10 min. After cooling, a silane solution (2% N-3-triethoxysilypropyl-4-hydroxybutramide [Gelest] in 95% ethanol [Acros], 0.1% acetic acid [Fisher Scientific]) was injected into the microchannel and incubated for 4 hours. The glass substrate was rinsed with a stock solution of 95% ethanol and 0.1% acetic acid, DI water, and baked at 120°C for 2 hours. The prepared PDMS microchannel (see Preparation of microchannel devices) was subsequently aligned and bonded (via oxygen plasma and heat) to the substrate. The just-silanized region on the glass substrate was protected with a piece of PDMS during plasma treatment. After PDMS bonding, 10 µL of the cross-linker, Sulfo-EGS, (3 mg/mL, Pierce) was injected into the microchannel for 20 minutes. Protein G (1 mg/mL, Pierce) was subsequently injected into the microchannel and incubated for 2-5 hrs. After incubation, excess Protein G was washed away with PBS. Antibodies (Table S1 ) at a concentration of 0.2-0.25 mg/mL (depending on stock concentration from the supplier, see Table S1 ) were injected into the prepared microchannel and incubated overnight at 4 o C. The microchannel was then flushed thoroughly with PBS, then media, and kept filled with media for cell screening.
Data acquisition and analysis:
A four-point measurement of the current was performed using a constant applied AC voltage (typically 0.2-0.4 V), as previously published [5] [6] [7] . The current was passed through a preamplifier (DL Instrument 1211) that performed a low-pass filter at 0.3 ms in rise time. The resulting output was connected to a data acquisition board (National Instruments PCI-6035E) for data sampling at 50 kHz. Data was recorded and analyzed using custom-written software in LabView. The raw data (green trace in Figure 1D ) underwent a three-point smoothing algorithm (red trace in Figure 1D ), and the derivative of the resulting smoothed data was plotted to identify the boundaries of each pulse.
Determination of cell size:
The relative height of a current pulse, δI/I, where δI is the absolute pulse magnitude and I is the baseline current, is dependent on the cell diameter, 
D was first determined experimentally by measuring the pulse magnitude of 15 um colloids (Bangs Laboratories) transiting the microchannel. The pulse magnitude was averaged over three runs on three different devices made with the same master. The effective diameter of the microchannel was determined to be D= 24 µm using Eq. 1. We subsequently were able to determine d for each cell measured.
To convert the recorded dimensionless δI/I value into cell size (µm), we make use of the Solver for Nonlinear Programming, which we install in OpenOffice by Oracle®. This NLP solver makes use of two evolutionary algorithms, Differential Evolution (DE) and Particle Swarm Evolution (PSE). For the purposes of this δI/I value into cell size (µm) conversion, we specifically utilize the Particle Swarm Optimization algorithm, which represents solution vectors as coordinate "particles" in an n-dimensional "room". As each particle traverses through the "room", it evaluates and keeps track of the best solution so far. The information is shared with the entire particle swarm, allowing for further iterations to be influenced by these current best solutions. Eventually, the particle swarm converges and stagnates around the optimal solution.
Screening primary-culture mouse myoblasts for Sca-1 and M-cadherin expression:
Primary-culture mouse myoblasts were isolated from freshly harvested mouse EDL muscle. Myoblasts were cultured in Matrigel-coated plates (2 μg/ml/cm 2 ) in Ham's F-10 media with 20% BGS, 1X penstrep, and 6 ng/ml FGF. Cells were dissociated from the matrigel in PBS with gentle agitation for 3-5 min to prevent digestion of surface receptors prior to screening. Figure  S1 A and B shows the τ-distributions derived from cells transiting an isotype-control, mouse IgG 2a (n = 141, τ = 3.16 ± 0.13 ms, Figure S1 A) and rabbit IgG (n = 218, τ = 1.44 ± 0.55 ms, Figure S1 B) microchannel, respectively. Figure S1 A and B show the τ-distributions derived from cells transiting an anti-Sca-1 (n = 1469, τ = 3.89 ± 0.35 ms, Figure S1 A) and anti-Mcadherin (n = 1004, τ = 4.45 ± 3.83 ms, Figure S1 B) antibody-coated microchannel, respectively.
To identify Sca-1 + /M-cadherin + cells among the cells that passed through an anti-Sca-1/anti-M-cadherin antibody microchannel, we first estimated the empirical probability density function for all cells passing through an IgG 2a control microchannel. With the estimated probability density function serving as a null distribution, we next computed the p-value and corresponding False Discovery Rate (FDR) for each cell passing through an anti-Sca-1/anti-M-cadherin antibody microchannel. The FDR was computed as follows: Let p(i) denote the ith largest pvalue among all cells. We estimated the corresponding FDR (when p(i) is used as a cutoff to determine Sca-1 + /M-cadherin + cells) by mp(i)/i, where m denotes an (overly) estimated number of Sca-1 -cells, e.g., m can be the total number of cells passing through the anti-Sca-1 antibody microchannel.
In a list of identified Sca-1 + /M-cadherin + cells, FDR controls the expected proportion of incorrect identifications of Sca-1 + /M-cadherin + cells (i.e., false positives) 8 . It is a less conservative procedure compared to the Bonferroni correction (see below), and especially preferred when a large number of tests are performed simultaneously.
Screening Sca-1 + cells in a bulk population of cells:
We compared the results of our screening method to those of FACS using satellite cells freshly harvested from mouse EDL muscle in bulk as published 9 . Figure + cells among the cells that passed through an anti-Sca-1 antibody microchannel, we performed a similar FDR analysis. The only difference from the previous analysis is that instead of using the empirical (i.e., non-parametric) probability density function, we used a parametric-way to estimate the probability density function (in a log-normal distribution family) for all cells passing through an IgG 2a control microchannel. We chose this parametric estimation because 1) the data fits the log-normal distribution very well and 2) there is less estimation of parameters involved so that the results are expected to be more robust. In our previous analysis for mouse myoblasts for Sca-1 and M-cadherin expression, the data does not seem to fit any parametric distribution we know and so a non-parametric estimation of the probability density function looks more appropriate.
A similar analysis was performed to identify Notch-1 + cells within a mixed population ( Figure  2C ).
Relationship between surface-epitope density and transit time:
To determine the relationship between the surface-epitope density and transit time through a microchannel functionalized with specific antibody, we performed a "blocking" experiment. A culture of Sca-1 + cells (typically ~70% Sca-1 + by FACS) was harvested from a plate by removing the growth media and incubating the cells in PBS for 3 minutes to dissociate the cells from the plate surface. The detached cells were spun down at 200 g for 5 minutes. The supernatant was removed, the cells were suspended in 3 mL of cell-staining buffer (Biolegend) and finally placed on ice. Purified Sca-1 antibodies (Biolegend) were mixed in concentrations of 1 µg/mL, 0.1 µg/mL, 0.01 µg/mL, 0.0005 µg/mL, and 0.0001 µg/mL in staining buffer. The Sca-1 + cells were divided into 6 different tubes (500 µL each) for incubation with the antibody at the different concentrations (1 µg/mL, 0.1 µg/mL, 0.01 µg/mL, 0.0005 µg/mL, 0.0001 µg/mL and 0 µg/mL). The 6 tubes were spun down at 200 g and the supernatant removed. 100 µl of antibody was then added to the cells and incubated on ice for 30 minutes. After incubation, the cells were spun down and washed 3 times with PBS. Cells were then re-suspended in PBS with 2 % FBS and placed on ice for analysis using a prepared microfluidic device.
Devices were fabricated and functionalized with the Sca-1 antibody (Biolegend) at a concentration of 0.25 µg/mL, as previously described. A separate device was used for each incubation condition. Cells were injected into the device and passed through the microchannel at 6.9 kPa. A minimum of 100 cells was measured for each incubation concentration. The cell transit time was measured and Figure S4 shows the average time subsequently determined for each condition. As shown in the figure, there is a decreasing transit time vs. increasing incubating antibody concentration (to the point of saturation), thus demonstrating that our timeof-flight measurement not only detects the presence of a specific surface antigen, but also relates to the expression level of that particular antigen. Simply, an increased number of specific satellite cells. Cells in green in Figure S3 corresponded to medium β1-integrin expression and had a raw p-value < 0.01. Further, cells in blue in Figure 3S corresponded to low β1-integrin expression and had a raw p-value < 0.05.
We note that the Dixon's Q test is a convenient and robust statistical test for identifying values that appear originated from a different distribution than the rest of the data, and it is particularly recommended for use in small samples 10 . The test statistic we used here took the ratio between the difference of the maximum value and its neighbor value and the difference of maximum and minimum values. We calculated the corresponding p-value by an existing R package. Figure 3A) , with conservative Bonferroni corrected p-values < 0.05, are identified as Sca-1 + associated satellite cells. The Bonferroni correction was applied here to address the problem of multiple comparisons, since we repeated the Dixon's Q test on all individual y ij 's, j =1,…,n i in each experiment. This correction helped control the overall family-wise false positive discovery rate: if the probability of false positives is  for an individual test (i.e., the test at a significance level of ), the overall familywise false positive discovery rate of n independent tests would be about n; the Bonferroni correction controls the family-wise probability of false positives by testing each of the individual tests at a significance level of /n. Cells in green in Figure 3A corresponded to medium Sca-1 expression and had an uncorrected p-value = 0.01. Further, cells in blue in Figure 3A corresponded to low Sca-1 expression and had an uncorrected p-value = 0.05. Similar analyses using the Dixon's Q Test and a Bonferroni correction were performed to determine high, medium, and low expressions of CXCR4 + , M-Cadherin + , and β1-Integrin 
Notch receptor screening:
Satellite cells were isolated from mouse muscle as described 3 . Briefly, muscle was dissected from the hind leg of 2-month old C57/black-6 mouse and incubated at 37 o C in digestion medium (200 U/mL Collagenase type II (Sigma) in DMEM, buffered with 10 mM HEPES, pH 7) for 2 hours with gentle agitation. After digestion the muscle was washed with PBS two times and triturated with a flame-polished broken pasteur pipette in buffered media (DMEM with 10% serum, buffered with 10 mM HEPES, pH7) in a shallow dish until the fibers were liberated. The dish containing the fibers was tilted to pool the liquid with fibers away from muscle chunks. The fibers were then transferred to a conical tube with additional buffered media and allowed to settle for 10 minutes, then washed two more times in buffered media before enzymatic digestion to liberate satellite cells (1 U/ml Dispase (Gibco), 40 U/ml Collagenase type II (Sigma) in DMEM, buffered with 10 mM HEPES, pH 7, for 1 hour with moderate agitation). The remaining debris was removed by gentle sedimentation (1 min, 200 x g), followed by filtration with a 40-50 µm mesh, and then the satellite cells were sedimented by centrifugation. The isolated satellite cells were then screened with microchannel devices functionalized with either anti-Notch1 antibody (Invitrogen, 0.2 mg/mL) or the isotype control IgG 1 (Invitrogen, 0.2 mg/mL). 2000 µm long microchannels were used to ensure maximum affinity to the microchannel. After screening, the cells were collected from the device and cultured in DMEM/F12 media with only 2 % horse serum so as not to further activate the cells. Cells from the original culture that were not screened with the microfluidic device were also plated overnight in 8-well plates coated with either anti-Notch1 antibody (Invitrogen, 0.2 mg/ml), which was a positive control for Notch activation, or the isotype control IgG 1 (Invitrogen, 0.2 mg/mL). Cells were fixed in ethanol and immunostained for activated Notch as described 11 ( Figure S6 A-D) . The number of cells with activated Notch was quantified by analyzing the fluorescence images using a custom-written program in Matlab: the Hoechst-stained image was converted to a binary format and the boundary of each nucleus was localized. The correlating Notch-stained image was then also converted to a binary format, and the boundary of nuclear Notch expression was localized. If the area of Notch expression was larger than the area of the nucleus, then all pixels within the boundary of Notch expression on the Notch-stained image are summed to generate a new boundary for that particular cell. If the area of the nucleus was larger than the area of Notch expression or no well-defined Notch-expression area could be identified for the corresponding nucleus, then all pixels that lie within the boundary of the nucleus in the Notch-stained image were summed. The boundaries were then transferred to the raw (i.e. not binary) image file and the fluorescence intensity inside each area determined to be a nucleus was summed ( Figure S6 E and F). Then for each selected area, the average per pixel background for that image multiplied by the number of pixels was subtracted, leaving a final quantification of the amount of fluorescence per nuclei. In order to filter out any small particles or random noise, any detected area smaller than 120 pixels ( Figure S6 G) was discarded. Cells that had a total fluorescence intensity of >2500 were considered to have high levels of nuclear Notch, and were subsequently considered to be activated ( Figure S6 H-K) .
Analysis of Sca-1 expression through immunofluorescence staining and microfluidic channel capture: Myofiber-associated satellite cells were isolated as published 3 . Cells were attached to matrigel-coated plates (2 μg/ml/cm 2 ) for 2 hours before immunostained for Sca-1 and Pax7. The cells were first live-stained for cell surface Sca-1 using Alexa 488 conjugated secondary antibodies (BD Biosciences), fixed in 4% paraformaldehyde, and washed and permeabilized before immunostaining for nuclear Pax7 (Developmental Studies Hybridoma Bank) as described 12 . .Fresh, isolated satellite cells were injected into a 100 µm x 2000 µm x 40,000 µm (H x W x L) microchannel functionalized with a saturating concentration of anti-Sca-1 antibody (Table 1) at a flow rate of 10 µL/min. Sca-1 + cells became bound to the functionalized antibodies, and therefore captured. As a control, freshly isolated satellite cells were also injected into the same-sized microchannel functionalized with IgG 2a control antibody. As expected, no cells were captured with the control channel. Sca-1 + cells captured in the anti-Sca-1 antibody channel were fixed in 4% paraformaldehyde, washed, and permeabilized before immunostaining for nuclear Myf5 (Santa Cruz Biotechnology).
Clonal analysis of single satellite cells: Single myofibers were isolated and analyzed with the devices. Immediately after screening for a pulse corresponding to a single satellite cell, the cell was collected in a separate well of 8-well cell culture dish. The cells were cultured in myoblast growth medium (DMEM/F12 with 10 % Bovine Growth Serum and 5 ng/mL FGF-2) for 14 days before immunostained for Pax7 and MyoD. Cell number, Pax7 + , MyoD + , and Pax7 + /MyoD + cell percentage were quantified for each cell colony.
